Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1989 Mar;66(3):422–427.

A study on type II collagen-induced arthritis in allogeneic bone marrow chimaeras.

M Fujita 1, M Mishima 1, K Iwabuchi 1, C Katsume 1, T Gotohda 1, K Ogasawara 1, Y Mizuno 1, R A Good 1, K Onoé 1
PMCID: PMC1385231  PMID: 2703256

Abstract

In the present investigation, the incidence, day of onset and severity of type II collagen (IIC)-induced polyarthritis (CA) in allogeneic bone marrow chimaeras were compared. These chimaeras were prepared by using reciprocal combinations between DBA/1J (H-2q, Igh-1c, Hc1), which are highly susceptible to CA, and SWR/J (H-2q, Igh-1c, Hc0), which are CA resistant, strains of mice. The four kinds of chimaeras, [SWR----DBA/1], [DBA/1----DBA/1], [DBA/1----SWR] and [SWR----SWR], were shown to be full chimaeras. [SWR----DBA/1] and [DBA/1----DBA/1] chimaeras showed serum C5 antigens and most of these mice developed CA, even though severity of CA in [SWR----DBA/1] chimaeras was less than that in [DBA/1----DBA/1] syngeneic chimaeras. By contrast, [DBA/1----SWR] and [SWR----SWR] chimaeras completely lacked serum C5 and did not develop CA at all. However, most of these chimaeras produced considerable total IgG and IgG2a antibodies to IIC in the sera after immunization with the antigens, although differences in the serum levels of IgG2a antibodies were seen between [SWR----DBA/1] and [DBA/1----SWR] allogeneic chimaeras. The present results demonstrate directly a crucial role of complement cascade in the induction and development of CA and reveal that lymphoid cells of SWR mice potentially have the ability to develop CA. Differences in severity of the CA observed in some of these chimaeras, however, could not be readily explained by differences in C5 concentrations alone.

Full text

PDF
422

Images in this article

424Figure 2
on p.424

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Banerjee S., Haqqi T. M., Luthra H. S., Stuart J. M., David C. S. Possible role of V beta T cell receptor genes in susceptibility to collagen-induced arthritis in mice. J Exp Med. 1988 Mar 1;167(3):832–839. doi: 10.1084/jem.167.3.832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brahn E., Trentham D. E. Attenuation of collagen arthritis and modulation of delayed-type hypersensitivity by type II collagen reactive T-cell lines. Cell Immunol. 1987 Oct 1;109(1):139–147. doi: 10.1016/0008-8749(87)90299-1. [DOI] [PubMed] [Google Scholar]
  3. Courtenay J. S., Dallman M. J., Dayan A. D., Martin A., Mosedale B. Immunisation against heterologous type II collagen induces arthritis in mice. Nature. 1980 Feb 14;283(5748):666–668. doi: 10.1038/283666a0. [DOI] [PubMed] [Google Scholar]
  4. Farkas A. I., Medgyesi G. A., Füst G., Miklós K., Gergely J. Immunogenicity of antigen complexed with antibody. I. Role of different isotypes. Immunology. 1982 Mar;45(3):483–492. [PMC free article] [PubMed] [Google Scholar]
  5. Farmer L. M., Watt G., Glatt M., Blaettler A., Loutis N., Feige U. Delayed type hypersensitivity (DTH) to type II collagen (CII) in DBA-1 mice. Clin Exp Immunol. 1986 Aug;65(2):329–335. [PMC free article] [PubMed] [Google Scholar]
  6. Herbage D., Bouillet J., Bernengo J. C. Biochemical and physiochemical characterization of pepsin-solubilized type-II collagen from bovine articular cartilage. Biochem J. 1977 Feb 1;161(2):303–312. doi: 10.1042/bj1610303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Holda J. H., Maier T., Claman H. N. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. I. Impairment of mitogen responses and suppressor phenomena. J Immunol. 1985 Mar;134(3):1397–1402. [PubMed] [Google Scholar]
  8. Holmdahl R., Jansson L., Gullberg D., Rubin K., Forsberg P. O., Klareskog L. Incidence of arthritis and autoreactivity of anti-collagen antibodies after immunization of DBA/1 mice with heterologous and autologous collagen II. Clin Exp Immunol. 1985 Dec;62(3):639–646. [PMC free article] [PubMed] [Google Scholar]
  9. Holmdahl R., Jansson L., Meyerson B., Klareskog L. Oestrogen induced suppression of collagen arthritis: I. Long term oestradiol treatment of DBA/1 mice reduces severity and incidence of arthritis and decreases the anti type II collagen immune response. Clin Exp Immunol. 1987 Nov;70(2):372–378. [PMC free article] [PubMed] [Google Scholar]
  10. Holmdahl R., Klareskog L., Rubin K., Larsson E., Wigzell H. T lymphocytes in collagen II-induced arthritis in mice. Characterization of arthritogenic collagen II-specific T-cell lines and clones. Scand J Immunol. 1985 Sep;22(3):295–306. doi: 10.1111/j.1365-3083.1985.tb01884.x. [DOI] [PubMed] [Google Scholar]
  11. Hom J. T., Stuart J. M., Tovey J., Chiller J. M. Murine T cells reactive to type II collagen. II. Functional characterization. J Immunol. 1986 Feb 1;136(3):776–782. [PubMed] [Google Scholar]
  12. Kakimoto K., Katsuki M., Hirofuji T., Iwata H., Koga T. Isolation of T cell line capable of protecting mice against collagen-induced arthritis. J Immunol. 1988 Jan 1;140(1):78–83. [PubMed] [Google Scholar]
  13. Koga Y., Tanaka K., Yokoyama M., Taniguchi K., Nomoto K. Thymus cell migration in a prostaglandin-mediated system. Immunobiology. 1985 Jul;169(5):486–502. doi: 10.1016/S0171-2985(85)80004-8. [DOI] [PubMed] [Google Scholar]
  14. Kresina T. F. Immunotherapy of experimental arthritis. Analysis of the articular cartilage of mice suppressed for collagen-induced arthritis by a T-cell hybridoma. Am J Pathol. 1987 Nov;129(2):257–266. [PMC free article] [PubMed] [Google Scholar]
  15. Marrack P., Lo D., Brinster R., Palmiter R., Burkly L., Flavell R. H., Kappler J. The effect of thymus environment on T cell development and tolerance. Cell. 1988 May 20;53(4):627–634. doi: 10.1016/0092-8674(88)90578-8. [DOI] [PubMed] [Google Scholar]
  16. Morgan K., Clague R. B., Shaw M. J., Firth S. A., Twose T. M., Holt P. J. Native type II collagen--induced arthritis in the rat: the effect of complement depletion by cobra venom factor. Arthritis Rheum. 1981 Nov;24(11):1356–1362. doi: 10.1002/art.1780241104. [DOI] [PubMed] [Google Scholar]
  17. Ogasawara M., Iwabuchi K., Ogasawara K., Noguchi M., Geng L., Good R. A., Morikawa K., Onoé K. Generation of cytotoxic T lymphocyte responses to allo-H-2 antigens in allogeneic bone marrow chimeras histocompatible at the H-2 subregions. Immunobiology. 1986 Aug;172(1-2):128–142. doi: 10.1016/s0171-2985(86)80059-6. [DOI] [PubMed] [Google Scholar]
  18. Onoé K., Fernandes G., Good R. A. Humoral and cell-mediated immune responses in fully allogeneic bone marrow chimera in mice. J Exp Med. 1980 Jan 1;151(1):115–132. doi: 10.1084/jem.151.1.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Onoé K., Fernandes G., Shen F. W., Good R. A. Sequential changes of thymocyte surface antigens with presence or absence of graft-vs-host reaction following allogeneic bone marrow transplantation. Cell Immunol. 1982 Apr;68(2):207–219. doi: 10.1016/0008-8749(82)90106-x. [DOI] [PubMed] [Google Scholar]
  20. Onoé K., Yasumizu R., Oh-Ishi T., Kakinuma M., Good R. A., Fernandes G., Morikawa K. Specific elimination of the T lineage cells: effect of in vitro treatment with anti-Thy 1 serum without complement on the adoptive cell transfer system. J Immunol Methods. 1982 Mar 26;49(3):315–322. doi: 10.1016/0022-1759(82)90131-4. [DOI] [PubMed] [Google Scholar]
  21. Onoé K., Yasumizu R., Oh-Ishi T., Kakinuma M., Good R. A., Morikawa K. Restricted antibody formation to sheep erythrocytes of allogeneic bone marrow chimeras histoincompatible at the K end of the H-2 complex. J Exp Med. 1981 Apr 1;153(4):1009–1014. doi: 10.1084/jem.153.4.1009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Seki N., Sudo Y., Yoshioka T., Sugihara S., Fujitsu T., Sakuma S., Ogawa T., Hamaoka T., Senoh H., Fujiwara H. Type II collagen-induced murine arthritis. I. Induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity. J Immunol. 1988 Mar 1;140(5):1477–1484. [PubMed] [Google Scholar]
  23. Stuart J. M., Cremer M. A., Townes A. S., Kang A. H. Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis. J Exp Med. 1982 Jan 1;155(1):1–16. doi: 10.1084/jem.155.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Stuart J. M., Dixon F. J. Serum transfer of collagen-induced arthritis in mice. J Exp Med. 1983 Aug 1;158(2):378–392. doi: 10.1084/jem.158.2.378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Stuart J. M., Townes A. S., Kang A. H. Nature and specificity of the immune response to collagen in type II collagen-induced arthritis in mice. J Clin Invest. 1982 Mar;69(3):673–683. doi: 10.1172/JCI110495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Trentham D. E., Townes A. S., Kang A. H. Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med. 1977 Sep 1;146(3):857–868. doi: 10.1084/jem.146.3.857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Wood F. D., Pearson C. M., Tanaka A. Capacity of mycobacterial wax D and its subfractions to induce adjuvant arthritis in rats. Int Arch Allergy Appl Immunol. 1969;35(5):456–467. doi: 10.1159/000230198. [DOI] [PubMed] [Google Scholar]
  28. Wooley P. H., Luthra H. S., Stuart J. M., David C. S. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med. 1981 Sep 1;154(3):688–700. doi: 10.1084/jem.154.3.688. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES